Results 141 to 150 of about 6,607 (210)

GRP78 Nanobody-Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy. [PDF]

Adv Sci (Weinh)
Wang H, Zhou R, Xu C, Dai L, Hou R, Zheng L, Fu C, Shi G, Wang J, Li Y, Cen J, Xu X, Yu L, Li Y, Wang J, Du Q, Li Z.   +16 more
europepmc   +1 more source

Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study. [PDF]

Gut
Szeto CC, Ng JKC.
europepmc   +1 more source

Critical appraisal of "A cross-sectional study on the effects of intravesical BCG on urinary microbiota in bladder cancer patients". [PDF]

Ann Med Surg (Lond)
Ali HS, Bilal E, Noor H, Khalid M, Ria SG.   +4 more
europepmc   +1 more source

Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of SIV. [PDF]

JCI Insight
Simpson J, Starke CE, Ortiz AM, Ransier A, Darko S, Llewellyn-Lacey S, Fennessey CM, Keele BF, Douek DC, Price DA, Brenchley JM.   +10 more
europepmc   +1 more source

cMPL-based purification and depletion of human hematopoietic stem cells: implications for pretransplant conditioning.

Blood
Araki D, Hong SG, Linde N, Fisk B, Redekar N, Salisbury-Ruf C, Krouse A, Engels T, Golomb J, Dagur P, Panicker SR, Kanthi Y, Magnani DM, Wang Z, Larochelle A.   +14 more
europepmc   +1 more source

Single-Chain Variable Fragment Fusion Proteins for Targeted Delivery and Therapy. [PDF]

Pharmaceuticals (Basel)
Yang L, Yin Y, Liu X, Guo B.
europepmc   +1 more source

Immunotoxins

Biomedicine & Pharmacotherapy, 1989
openaire   +1 more source

Lethal toxin-equipped effector cells for the potential treatment of cancer. [PDF]

Proc Natl Acad Sci U S A
Pearlman AH, Mog BJ, Hwang MS, Rincon-Torroella J, DiNapoli SR, Paul S, Douglass J, Hsiue EH, Glavaris SA, Pardoll DM, Papadopoulos N, Kinzler KW, Bettegowda C, Zhou S, Vogelstein B, Konig MF.   +15 more
europepmc   +1 more source

Targeting the CD47-TSP1 Axis in Abdominal Aortic Aneurysm: A Novel Immunotherapeutic Approach. [PDF]

Int J Mol Sci
Stępień KL, Janas K, Rojek S.
europepmc   +1 more source

In vitro evidence of HER2-selective cytotoxicity by scFv(Herceptin)-PE-STXA immunotoxin in gastric cancer cells. [PDF]

Biochem Biophys Rep
Sedighian H, Abdi A, Goleij Z, Fasihi-Ramandi M, Fooladi AAI.   +4 more
europepmc   +1 more source